BACKGROUND: Dopamine agonist therapy is the main risk factor for impulse control disorders in Parkinson's disease (PD). However, it is unclear whether bilateral deep brain stimulation of the subthalamic nucleus also causes impairment in decision making. OBJECTIVES: To assess the role of dopamine agonist therapy and deep brain stimulation on reflection impulsivity in non-demented patients with PD. METHODS: We recruited 61 PD patients, 20 treated with L-dopa in combination with a dopamine agonist, 14 taking L-dopa monotherapy, a further 16 PD patients with bilateral subthalamic nucleus deep brain stimulation treated with L-dopa in combination with a dopamine agonist, and 11 PD patients with bilateral subthalamic nucleus deep brain stimulation taking L-dopa but not a dopamine agonist. Results were compared with 18 healthy controls. Patients who had evidence of impulsive compulsive behaviour were excluded. Reflection impulsivity was assessed with the beads task, which is a validated information sampling task. RESULTS: All patients treated with a dopamine agonist gathered significantly less information and made more irrational decisions than all other groups regardless of whether they had surgical treatment. CONCLUSIONS: Our results imply that dopamine agonist therapy but not deep brain stimulation leads to "reflection impulsivity" in PD.
BACKGROUND:Dopamine agonist therapy is the main risk factor for impulse control disorders in Parkinson's disease (PD). However, it is unclear whether bilateral deep brain stimulation of the subthalamic nucleus also causes impairment in decision making. OBJECTIVES: To assess the role of dopamine agonist therapy and deep brain stimulation on reflection impulsivity in non-demented patients with PD. METHODS: We recruited 61 PDpatients, 20 treated with L-dopa in combination with a dopamine agonist, 14 taking L-dopa monotherapy, a further 16 PDpatients with bilateral subthalamic nucleus deep brain stimulation treated with L-dopa in combination with a dopamine agonist, and 11 PDpatients with bilateral subthalamic nucleus deep brain stimulation taking L-dopa but not a dopamine agonist. Results were compared with 18 healthy controls. Patients who had evidence of impulsive compulsive behaviour were excluded. Reflection impulsivity was assessed with the beads task, which is a validated information sampling task. RESULTS: All patients treated with a dopamine agonist gathered significantly less information and made more irrational decisions than all other groups regardless of whether they had surgical treatment. CONCLUSIONS: Our results imply that dopamine agonist therapy but not deep brain stimulation leads to "reflection impulsivity" in PD.
Authors: James F Cavanagh; Thomas V Wiecki; Michael X Cohen; Christina M Figueroa; Johan Samanta; Scott J Sherman; Michael J Frank Journal: Nat Neurosci Date: 2011-09-25 Impact factor: 24.884
Authors: Laura B Zahodne; Frandy Susatia; Dawn Bowers; Tiara L Ong; Charles E Jacobson; Michael S Okun; Ramon L Rodriguez; Irene A Malaty; Kelly D Foote; Hubert H Fernandez Journal: J Neuropsychiatry Clin Neurosci Date: 2011 Impact factor: 2.198
Authors: Bruno B Averbeck; Simon Evans; Viraj Chouhan; Eleanor Bristow; Sukhwinder S Shergill Journal: Schizophr Res Date: 2011-04 Impact factor: 4.939
Authors: Sarah J Moum; Catherine C Price; Natlada Limotai; Genko Oyama; Herbert Ward; Charles Jacobson; Kelly D Foote; Michael S Okun Journal: PLoS One Date: 2012-01-25 Impact factor: 3.240
Authors: Atbin Djamshidian; Sean S O'Sullivan; Alessandro Tomassini; Thomas Foltynie; Patricia Limousin; Iciar Aviles-Olmos; Thomas T Warner; Andrew J Lees; Bruno B Averbeck Journal: J Parkinsons Dis Date: 2014 Impact factor: 5.568
Authors: Flavio Henrique de Rezende Costa; Bruno Averbeck; Sean S O'Sullivan; Maurice Borges Vincent; Ana Lucia Rosso; Andrew J Lees; Atbin Djamshidian Journal: Neuropsychologia Date: 2016-03-05 Impact factor: 3.139
Authors: David A Ziegler; Paymon Ashourian; Julien S Wonderlick; Alison K Sarokhan; Drazen Prelec; Clemens R Scherzer; Suzanne Corkin Journal: Scand J Psychol Date: 2014-04-21
Authors: Atbin Djamshidian; Jennifer Mulhall; Alessandro Tomassini; Grace Crotty; Thomas T Warner; Andrew Lees; Sean S O'Sullivan; Bruno B Averbeck Journal: Mov Disord Clin Pract Date: 2014-07-31
Authors: Valerie Voon; Yee Chien Chang-Webb; Laurel S Morris; Ella Cooper; Arjun Sethi; Kwangyeol Baek; Jon Grant; Trevor W Robbins; Neil A Harrison Journal: Int J Neuropsychopharmacol Date: 2015-06-30 Impact factor: 5.176
Authors: Raquel Vicario-Feliciano; Rebekah L Wigton; Thomas P White; Sukhi S Shergill; Bruno B Averbeck Journal: J Psychopharmacol Date: 2019-01-15 Impact factor: 4.153